Repligen to acquire BioLife Solutions for $11.25 cash plus stock
BioLife Solutions agreed to be acquired by Repligen for $11.25 cash and 0.1442 shares of Repligen stock per BioLife share.
Key Highlights:Original SEC Filing: BIOLIFE SOLUTIONS INC [ BLFS ] - 8-K - Sep. 09, 2026This is an AI-powered summary. It may contain inaccuracies. Consider verifying important…